FLG249 通过诱导核心压缩剂和联合激活剂从FXR分离而表现出FXR对手活动
Yusuke Iguchi1, Yukiko Yamashita1, Keigo Gohda2
1Faculty of Pharmaceutical Sciences, Hiroshima International University, Kure, Hiroshima 737-0112, Japan.
法尔内索伊德X受体 (FXR) 抗剂FLG249通过减少协活性剂和核心压缩剂相互作用来独特调节FXR,为代谢性疾病疗法提供了潜力.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 华氏体X受体 (FXR) 调节胆酸,脂质和碳水化合物代谢.
- 包括对抗剂在内的FXR配体是代谢疾病的潜在治疗药物.
- 确切的FXR抗剂作用机制尚不清楚.
研究的目的:
- 阐明FXR对抗剂FLG249抑制FXR活动的机制.
- 描述FLG249对FXR与联合激活器和核心压力器相互作用的影响.
主要方法:
- LanthaScreenTM 时间分辨率光能量转移试验.
- 两种混合测试来评估FLG249对FXR的影响.
主要成果:
- 结合FXR的FLG249降低了它与联合激活剂和核心压缩剂的相互作用.
- 这种双相互作用调制使FLG249与其他核受体调制器有所区别.
结论:
- 作为一个FXR调节器,FLG249表现出一种新的作用机制.
- 这种独特的机制表明了代谢障碍的独特治疗潜力.
更多相关视频
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
11:10Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
相关概念视频
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
GPCR Desensitization
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
GPCRs Regulate Adenylyl Cylase Activity
